Aeroallergen immunotherapy associated with reduced risk of severe COVID-19 in 1095 allergic patients.
Larenas-Linnemann D, Morfin-Maciel BM, Bedolla-Barajas M, López-Bago A, Navarrete Rodríguez EM, Mogica-Martínez MD, Gereda JE, Sarrazola Sanjuan M, Cano Pedroza RY, Cavallo MC, Romero Tapia SJ, Jossen RA, Fuentes Pérez JM, Del Rio Navarro BE, Rodríguez Zagal E, Piraino Sosa PA, Huerta Villalobos YR, Chavez-Vereau P, García Imperial DA, Olivares Gómez M, Valle Rodríguez F, Zuñiga Reyes CO, Rodríguez-González M, Gallego Corella CI, Ivancevich JC, García Cruz MLH, Repka-Ramirez MS, Flores Morales ME, Fernández De Córdova Aguirre JC, Luna-Pech JA, Rivero Yeverino D, Martínez Guzmán E, Pérez Ortiz CE, Villa Médica L.
Larenas-Linnemann D, et al. Among authors: romero tapia sj.
World Allergy Organ J. 2023 May;16(5):100779. doi: 10.1016/j.waojou.2023.100779. Epub 2023 May 3.
World Allergy Organ J. 2023.
PMID: 37251811
Free PMC article.